Loading
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Previous close
$26.23
−$0.57 · -2.13%
Regular session · ET · Market data may be delayed.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Day range
Current $26.23
52-week range
Current $26.23
Regular session · ET · Market data may be delayed.
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.
Day range
Current $26.23
52-week range
Current $26.23
Third-party consensus; not a GoAI recommendation.
Average target
$60.00
128.75% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.54M0.00%2.3T USD0.03%$376.31+0.82%
Vanguard Extended Market ETFVXF575.95K0.00%93.7B USD0.05%$237.76+0.68%
Vanguard Russell 2000 ETFVTWO197.7K0.00%17.4B USD0.06%$116.76+0.36%
JPMorgan Healthcare Leaders ETFJDOC33.47K0.37%9.1M USD0.65%$60.7158-1.16%
Vanguard Russell 2000 Growth ETFVTWG19.8K0.00%1.7B USD0.06%$268.4+0.57%
Vanguard Russell 2000 Value ETFVTWV7.13K0.00%1.4B USD0.06%$193.91+0.40%
Vanguard Russell 3000 ETFVTHR3.1K0.00%6.1B USD0.06%$337.14+0.87%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWOJPMorgan Healthcare Leaders ETFJDOCVanguard Russell 2000 Growth ETFVTWGVanguard Russell 2000 Value ETFVTWVVanguard Russell 3000 ETFVTHRAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
